Melanoma and Other Skin Cancers: Biology and Patient Management 2022

Saturday, October 29, 2022, 7:30 AM - 4:00 PM EST, Bethesda North Marriott Hotel & Conference Center, Rockville, MD


In this interdisciplinary conference, an expert, faculty will present clinical updates in melanoma and other skin cancer early disease management. This includes novel approaches to melanoma detection. In addition, exciting advances in the treatment of patients with high-risk and metastatic disease will be discussed with a special emphasis on the multidisciplinary approach to the care of patients with melanoma. Other sessions will feature new data on the role of neoadjuvant and adjuvant therapy, new treatments for patients with metastatic disease in both the front line and subsequent lines of therapy, novel cellular and T-cell engager therapies, changes in the role of surgery and a debate on the role of adjuvant therapy in patients with Stage II and IIIA melanoma. Interspersed throughout the day will be lectures on the latest approaches to the management of non-melanoma skin cancers and dermatologic toxicities from systemic therapies. Case presentations will address complex and controversial management issues in patients with high-risk and advanced melanoma and non-melanoma skin cancer.

1. Analyze and apply new insights in the diagnosis and treatment of melanoma.
2. Discuss the new data with cellular therapy and T-cell engagers in the management of patients with advanced melanoma.
3. Discuss sequencing of immune and targeted therapy vs combinations in patients with BRAF mutant melanoma.
4. Incorporate salvage surgery in selected patients with Stage IV disease to enhance long term outcomes.
5. Discuss evolving research and treatment options for patients with disease resistant to IO +/- BRAF/MEK inhibitor therapy.
6. Recognize the value of multidisciplinary evaluation and assessment, in contributing to more effective and expedited patient treatment.
7. Describe the approach to management of dermatologic toxicities in patients receiving systemic therapy for melanoma and other skin cancers.
8. Apply new data on adjuvant and neoadjuvant therapy.
9. Identify the roles and responsibilities of members of the healthcare team involved in the collaborative care of patients with melanoma or other skin cancers.
10. Integrate a team-based approach in the care of patients with melanoma or other skin cancers.
11. Analyze and apply new insights in the treatment of non-melanoma skin cancers.
12. Discuss new data on the approaches to first line treatment for patients with metastatic melanoma and how to choose one treatment over another.

Physician  $100
Resident or Fellow  $75
Physician Assistant  $75
Nurse Practitioner  $75
Nurse  $75
Allied Health Professional  $75
Medical Student  $75
Industry Professional  $200

In support of improving patient care, MedStar Health is jointly accredited by the   Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 7.00 Interprofessional Continuing Education (IPCE) credits for learning and change.





Physicians: MedStar Health designates this Live Activity for a maximum of 7.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Nurses: This activity is approved for 7.00 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

MedStar Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 7.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

 

  Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

 Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn  7.00 credits toward the CME of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

Learner participates by writing a reflective statement and makes a commitment to change or maintain an element of practice.

AMA PRA Category 1 Credits™ Physician (7.00 hours), Nurse - ANCC (7.00 hours), Non-Physician Member of the Healthcare Team (7.00 hours), Physician Assistant - AAPA (7.00 hours), IPCE (7.00 hours), ABIM MOC Part 2 (7.00 hours), ABPath MOC Part II (7.00 hours), ABS CC (7.00 hours), ABS CC SAM (7.00 hours)

Bethesda North Marriott Hotel & Conference Center
5701 Marinelli Rd, Rockville, MD 20852
(301) 822-9200
Hotel Website

Mitigation of Relevant Financial Relationships

MedStar Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education.

Individuals in a position to control the content of this CE activity, including faculty, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible companies. An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships listed below have been mitigated prior to the commencement of the activity.

Saturday, October 29, 2022

Please contact Elizabeth Romano at [email protected] for information on exhibiting at this conference.